Status:
COMPLETED
Multicenter Study of the Protector Laryngeal Mask
Lead Sponsor:
Matilde Zaballos
Collaborating Sponsors:
Teleflex
Conditions:
Airway
Eligibility:
All Genders
18-75 years
Brief Summary
The study was designed to evaluate the success rate, time of insertion, sealing efficacy and security of the Protector Laryngeal Mask, a new second generation disposable supraglottic airway device, in...
Detailed Description
Laryngeal masks (LM) and supraglottic devices (SGD), in all their different forms, have become an authentic innovation in airway management especially in day surgery. LMA Protector (Teleflex Medical,...
Eligibility Criteria
Inclusion
- Surgery procedures usually performed with supraglottic devices.
- ASA physical status I-III patients
- Age 18-75
- Signed inform consent
Exclusion
- Patients with known difficult airway
- Patients with predicted difficult airway
- Patients with increased risk of aspiration
- Patient refusal to participate in the study.
Key Trial Info
Start Date :
August 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2018
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT03272776
Start Date
August 1 2017
End Date
July 30 2018
Last Update
February 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Servicio de Anestesia, Hospital General Universitario Gregorio Marañon
Madrid, Spain, 28007